title: [Our experience with mitomycin C in the prophylaxis of superficial bladder tumors; retrospective study].
abstract: From 1984 to 1991, fifty-one patients completed prophylactic endovesical treatment with mitomycin C after transurethral resection of a bladder carcinoma Ta, Tl. The mean disease-free period was 31.2 months; twenty patients had recurrences (39.2%) and five (9.8%) had a progression in tumor stage. No statistically significant differences were found relative to the recurrences and tumor number, stage and size. The patients with prior tumors had recurrences before (p < 0.05) and more times (p < 0.01) than the primary group.
authors: Servicio de Urología, Hospital de la Princesa, Madrid, España.
authors: J L
authors: JL
authors: Moyano Calvo
authors: L
authors: L
authors: Herrero Torres
authors: F J
authors: FJ
authors: Melón Rey
authors: M
authors: M
authors: Rabadán Ruiz
authors: I
authors: I
authors: Pereira Sanz
mesh_terms: D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D016685:Mitomycin / Q000627:therapeutic use*; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology / Q000517:prevention & control*; D012189:Retrospective Studies; D001749:Urinary Bladder Neoplasms / Q000453:epidemiology / Q000517:prevention & control*
chemical_list: D016685:Mitomycin
vernacular_title: Nuestra experiencia con mitomicin C como profilaxis en los tumores superficiales de vejiga; estudio retrospectivo.